The Singapore Health Sciences Authority has approved clinical trials for a coronavirus vaccine candidate being developed by Arcturus Therapeutics and Duke-NUS School of Medicine. Arcturus, a biopharmaceutical company based in San Diego, California, in association with Duke-NUS of Singapore, said they will begin human dosage testing as soon as possible. …
Read More »Singapore clinical trials for the Arcturus and Duke-NUS vaccine candidate
